Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:1511-1512 (24 June), doi:10.1136/bmj.332.7556.1511-c
| The first 150 words of the full text of this article appear below. |
EDITORThe audit by Bampton et al highlights the practical problems encountered in the area of Barrett's oesophagus surveillance.1 Our retrospective audit of 441 patients with Barrett's oesophagus in a university teaching hospital setting showed an alarmingly low compliance rate of 8.6%.2 The main area of concern was that quadrantic biopsies were not taken in a large proportion of patients. Similar figures were seen in an audit in United States, where the compliance rates varied from 14% to 38% in a patient population from both teaching hospitals and community centres.3 As seen by Bampton et al, the prospective audit in our centre after guidelines were disseminated among endoscopists showed improved compliance only to 61%. The main reasons for lack of compliance continues to be the lack of dedicated endoscopy lists with extended time allocation and the ongoing debate between believers and non-believers of a surveillance strategy in Barrett's.
| |||||||||||
Shaji Sebastian, consultant gastroenterologist
Hull Royal Infirmary, Hull HU3 2JZ shaji.sebastian@hey.nhs.uk
Colm O'Morain, head
Department of Gastroenterology, Adelaide and Meath Hospital, Dublin 24, Republic of Ireland